Meyer Robert J.
- SEC CIK
- 0001735298
No open-market purchases or sales filed in the past year.
Current role at each company
- AVLN Avalyn Pharma Inc.Directoras of Sep 17, 2026
- CMRX Chimerix IncDirectoras of Apr 21, 2025
- Translate Bio, Inc.Directoras of Sep 14, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Meyer Robert J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CMRX Chimerix Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2023 (view filing) | May 8 | 2 days | Meyer Robert J.Director | PPurchase | +8.75K | $1.14 | +$9.97K | +33.1%35.1K after | |
| May 20, 2022 (view filing) | May 19 | 1 day | Meyer Robert J.Director | PPurchase | +11.4K | $2.06 | +$23.5K | +76.0%26.4K after | 2 lots |
Translate Bio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Meyer Robert J.Director | SSale | −95.6K | $0.00 | $0 | –0 after | Derivative4 lots |